Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.840
0.00 (-0.02%)
At close: Jul 19, 2024, 4:00 PM
0.780
-0.060 (-7.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $44.71 million as of July 22, 2024. Its market cap has decreased by -26.46% in one year.
Market Cap
44.71M
Enterprise Value
34.12M
1-Year Change
-26.46%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $44.71M, a decrease of -91.30%. That is a compound annual growth rate of -58.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 43.80M | -30.48% |
| Dec 29, 2023 | 63.00M | 18.42% |
| Dec 30, 2022 | 53.20M | -73.09% |
| Dec 31, 2021 | 197.70M | -61.55% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 46.44M |
| DURECT | 46.40M |
| Apyx Medical | 46.25M |
| Daxor | 45.85M |
| Marker Therapeutics | 45.84M |
| CalciMedica | 45.43M |
| NeueHealth | 45.15M |
| Mobile-health Network Solutions | 45.05M |